Stacy Amin was quoted in the Bloomberg Law article “FDA Braces for High Court, Final Rule Moves in Election Year.” The article highlights the anticipated moves by the Food and Drug Administration on long-awaited rules and guidance for 2024. The agency’s plans include regulating lab-developed tests, banning certain tobacco products, issuing guidelines for medical devices and artificial intelligence, and action to ameliorate drug shortages.
Stacy says, “We could see a really busy year because the agency is going to want to clear as many priorities as they can. It will want to clear off its plate before it gets into a window of time where new administration could come in and reconsider policies that have been put in place.”
Read the full article. (subscription required)